ProCE Banner Activity

My Key Points on Outpatient Influenza Management in the Immunosuppressed Population

Clinical Thought
Mitigating influenza morbidity and mortality in immunosuppressed patients requires timely preventative and therapeutic decisions. Healthcare professionals now have greater options for diagnostics and treatment.

Released: August 05, 2021

Expiration: August 04, 2022

No longer available for credit.

Share

Faculty

Paul G. Auwaerter

Paul G. Auwaerter, MD

Sherrilyn and Ken Fisher Professor of Medicine
Clinical Director
Division of Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, Maryland

Supporters

This activity is supported by an educational grant from

Genentech, a member of the Roche Group

Faculty Disclosure

Primary Author

Paul G. Auwaerter, MD

Sherrilyn and Ken Fisher Professor of Medicine
Clinical Director
Division of Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, Maryland

Dr Auwaerter: consulting fees: EMD Serono, Verily; contracted research: Humanigen; other financial or material support: Johnson & Johnson.